The Betel Nut Intervention Trial (BENIT)—A Randomized Clinical Trial for Areca Nut and Betel Quid Cessation: Primary Outcomes
International Journal of Environmental Research and Public Health · 21.08.2023 · 20 (16) · 6622
DOI: 10.3390/ijerph20166622 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Environmental Research and Public Health, online erschienen am 21.08.2023. Verfasst von Thaddeus A Herzog und 10 weiteren Autor:innen. Beteiligte Einrichtung: University of Hawaii Cancer Center, University of Hawaii at Manoa, 701 Ilalo Street, Honolulu, HI 96813, USA. Hauptthemen laut MEDLINE: Areca, Nuts. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute: The University of Guam/University of Hawaii Cancer Center Partnership to Advance Cancer Health Equity, University of Hawaii Cancer Center Support.
Abstract (Originalsprache)
Background
Areca nut and betel quid (ANBQ) chewing is a widespread carcinogenic habit. The BENIT (ClinicalTrials—NCT02942745) is the first known randomized trial designed for ANBQ chewers.
Methods
We compared the intensive behavioral treatment intervention condition (IC) with the control condition (CC) in the BENIT and included a 5-stage early stopping rule. We report the primary analysis at stage 3. English-literate adults in Guam and Saipan who self-identified as ANBQ chewers with tobacco were enrolled between August 2016 and August 2020. IC participants (n = 88) received five in-person sessions over 22 days and a brochure containing quitting advice. CC participants (n = 88) received only the brochure. Participants were assessed at baseline and on day 22 of follow-up. Self-reported chewing status at day 22 was determined by a composite of two survey items with disparate wording and response options for cross-verification.
Results
Cessation rates were 38.6% (IC) and 9.1% (CC). Proportional hazards regression revealed a p = 0.0058, which met the Stage 3 criteria for significance, and an estimated reduction in ANBQ chewing for IC compared to the CC of 71% (95% CI: 41%–88%).
Conclusions
Robust self-reported intervention effects at day 22 suggest that intensive cessation programs such as BENIT should be further developed and implemented on a larger scale.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Hawaii Cancer Center, University of Hawaii at Manoa, 701 Ilalo Street, Honolulu, HI 96813, USA.
- University of Guam Cancer Research Center, University of Guam, Mangilao, GU 96923, USA.
ORCID-Profile: Thaddeus A Herzog, Lynne R Wilkens, Grazyna Badowski, Crissy T Kawamoto
Förderung
- NCI NIH HHS
- National Cancer Institute: The University of Guam/University of Hawaii Cancer Center Partnership to Advance Cancer Health Equity
- University of Hawaii Cancer Center Support
Zitieren
APA
Herzog, T. A., Wilkens, L. R., Badowski, G., Mendez, A. J. P., Franke, A. A., Pokhrel, P., Chennaux, J. S. N., Tenorio, L. F., Sotto, P. P., Kawamoto, C. T., & Paulino, Y. C. (2023). The Betel Nut Intervention Trial (BENIT)—A Randomized Clinical Trial for Areca Nut and Betel Quid Cessation: Primary Outcomes. International Journal of Environmental Research and Public Health, 20(16), 6622. https://doi.org/10.3390/ijerph20166622
Vancouver
Herzog TA, Wilkens LR, Badowski G, Mendez AJP, Franke AA, Pokhrel P, et al. The Betel Nut Intervention Trial (BENIT)—A Randomized Clinical Trial for Areca Nut and Betel Quid Cessation: Primary Outcomes. International Journal of Environmental Research and Public Health. 2023;20(16):6622. doi:10.3390/ijerph20166622
BibTeX
@article{Herzog2023,
author = {Herzog, Thaddeus A and Wilkens, Lynne R and Badowski, Grazyna and Mendez, Ana Joy Pacilan and Franke, Adrian A and Pokhrel, Pallav and Chennaux, Jade S N and Tenorio, Lynnette F and Sotto, Patrick P and Kawamoto, Crissy T and Paulino, Yvette C},
title = {The Betel Nut Intervention Trial (BENIT)—A Randomized Clinical Trial for Areca Nut and Betel Quid Cessation: Primary Outcomes},
journal = {International Journal of Environmental Research and Public Health},
year = {2023},
volume = {20},
number = {16},
pages = {6622},
doi = {10.3390/ijerph20166622}
}
EUVIMED